Redmile Group, LLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Amicus Therapeutics, Inc. (FOLD)

Filing Manager: Redmile Group, LLC
Reporting Manager: Redmile Group, LLC
Security: Amicus Therapeutics, Inc. Common Stock, par value $0.01 per share
Symbol: FOLD
Shares outstanding: 308M shares
Disclosed Ownership: 14.2M shares
Ownership: 4.6%
Form type: SCHEDULE 13G/A
Date filed: 2/14/2025, 08:00 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Redmile Group, LLC	4.6%	14.2M	0	14.2M	/s/ Jeremy C. Green	Managing Member
Jeremy C. Green	4.6%	14.2M	0	14.2M	/s/ Jeremy C. Green	Jeremy C. Green